Intravascular Ultrasound Systems Market to Reach USD 1455.7 Million by 2035 with Advancements in Imaging

The intravascular ultrasound (IVUS) systems market is on track to record consistent growth over the next decade. Valued at USD 893.7 million in 2025, the market is expected to expand to USD 1455.7 million by 2035, reflecting a compound annual growth rate of 5.0%. With cardiovascular disease remaining one of the leading causes of mortality globally, the demand for advanced intravascular imaging technologies is escalating. IVUS systems, which provide real-time cross-sectional imaging of blood vessels, are becoming integral tools in interventional cardiology for diagnosing and treating coronary and peripheral artery diseases.

Why the Market is Growing

The steady growth of the IVUS systems market is being driven by multiple factors. Rising incidences of coronary artery disease, peripheral vascular disorders, and lifestyle-related conditions such as obesity and diabetes are creating higher demand for precision imaging. IVUS systems support cardiologists in assessing plaque burden, lesion characteristics, and vessel size, which is critical for guiding interventions like stent placement.

Technological innovations are also reshaping the market. Advances in catheter miniaturization, improved imaging resolution, and integration with other interventional devices are leading to safer, more efficient procedures. Hospitals and specialty clinics worldwide are increasingly investing in these systems, aligning with updated clinical guidelines that recommend intravascular imaging for complex cardiovascular interventions.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.futuremarketinsights.com/reports/sample/rep-gb-1858

Product Insights: IVUS Catheters Lead

Within product categories, IVUS catheters are projected to hold 21.6% of the market share in 2025, making them the leading segment. Catheters are indispensable in delivering high-resolution intravascular imaging during both coronary and peripheral interventions. With innovations such as smaller diameters, greater flexibility, and enhanced imaging transducers, modern IVUS catheters allow physicians to navigate complex anatomies with ease.

The growing number of percutaneous coronary interventions is further fueling catheter demand. Their integration with stent deployment and other interventional tools not only improves diagnostic accuracy but also enhances procedural outcomes, ensuring their position as a cornerstone of intravascular imaging technologies.

Application Analysis: Coronary Interventions Dominate

Coronary interventions will remain the largest application segment, representing 41.2% of the market’s revenue in 2025. As coronary artery disease continues to rise globally, IVUS is increasingly used to optimize stent selection, placement, and expansion. By providing detailed imaging of vessel dimensions and lesion morphology, IVUS helps reduce the risk of restenosis and improves long-term patient outcomes.

Clinical guidelines in North America, Europe, and Asia now recommend intravascular imaging for complex or high-risk coronary interventions. With the rising use of drug-eluting stents and advanced percutaneous coronary procedures, demand for IVUS in coronary interventions is expected to grow consistently.

End User Insights: Hospitals at the Forefront

Hospitals are anticipated to account for 58.6% of the market share in 2025, making them the largest end-user segment. High patient inflow for cardiovascular conditions, combined with access to advanced imaging infrastructure, supports their dominance. Hospitals are prioritizing the adoption of IVUS systems to enhance accuracy in diagnosing vascular conditions and to support evolving interventional cardiology guidelines.

Specialty cardiovascular institutes and cancer institutes are also adopting IVUS systems to strengthen their diagnostic and therapeutic capabilities. Integration of IVUS with other imaging modalities, such as angiography and optical coherence tomography (OCT), is allowing hospitals to develop comprehensive treatment workflows that improve patient care while reducing procedural risks.

Regional Landscape

In 2025, North America is expected to lead the market with strong adoption in the United States, where hospitals benefit from advanced healthcare infrastructure and higher purchasing power. The U.S. IVUS market alone is projected to be valued at USD 304.7 million in 2025 and reach USD 462.1 million by 2035, growing at a CAGR of 4.3%.

Asia-Pacific is set to become the second-largest region, with China and India driving growth at CAGRs of 6.8% and 6.3% respectively. Rising prevalence of cardiovascular disease, expanding healthcare investments, and growing adoption of minimally invasive procedures are accelerating adoption in these countries. Europe remains a stable and growing market, with Germany and France leading innovation and adoption rates.

Emerging economies in Latin America and the Middle East are gradually adopting IVUS technologies, supported by healthcare modernization initiatives and increasing awareness of advanced diagnostic imaging.

Technology Advancements

The technology underpinning IVUS systems continues to advance rapidly. The instrumentation typically consists of a catheter with a miniaturized ultrasound transducer at the tip and a console for image reconstruction. Frequencies vary from 12.5 MHz to 50 MHz, depending on the vessel size being scanned.

Two major transducer designs dominate: phased-array systems with multiple sequentially activated elements, and mechanical probes that rotate a transducer to generate images. These improvements enable higher-resolution imaging, quicker diagnostics, and enhanced integration with interventional procedures.

Ongoing innovation in catheter design, such as improved flexibility and reduced diameters, is making procedures less invasive and safer for patients. Companies are also integrating IVUS systems with AI and machine learning algorithms to improve diagnostic accuracy and procedural guidance.

Request Market Research Draft Report: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1858

Opportunities and Challenges

The market presents numerous opportunities for both established and emerging manufacturers. With cardiovascular disease burden rising worldwide, demand for precision imaging is unlikely to slow down. New manufacturers entering the space are exploring AI-driven imaging software, disposable IVUS catheters, and integrated consoles tailored for hospitals in emerging economies.

However, challenges remain. High costs of IVUS systems, lack of uniform reimbursement policies in some countries, and competition from alternative imaging modalities like OCT can slow adoption. Smaller healthcare facilities in developing markets may also face barriers due to limited infrastructure and budgets. Manufacturers are responding by developing cost-effective systems and collaborating with governments to improve reimbursement frameworks.

Competitive Landscape

The market is highly competitive, with leading players such as Boston Scientific Corporation, Philips Healthcare, Siemens Healthineers, GE Healthcare, Canon Medical Systems Corporation, and Terumo Corporation driving innovation. These established companies are continuously enhancing their product portfolios through R&D investments, strategic partnerships, and clinical collaborations.

Emerging companies like Conavi Medical Inc., Infraredx, Inc., Bay Labs, CardioFlow Medtech, and OpSens Medical are introducing novel catheter designs, software enhancements, and AI-enabled solutions that challenge incumbents and expand market diversity.

In addition, global medical technology giants like Medtronic plc, Abbott Laboratories, and Fujifilm Holdings Corporation are strengthening their foothold by leveraging broad distribution networks and integrated healthcare solutions. This mix of established leaders and innovative newcomers ensures steady technological progress and competitive pricing strategies that benefit healthcare providers worldwide.

Related Reports:

Coagulation Analysers Market: https://www.futuremarketinsights.com/reports/coagulation-analysers-market

Renal Function Test Market: https://www.futuremarketinsights.com/reports/renal-function-test-market

Pressure Bandages Market: https://www.futuremarketinsights.com/reports/pressure-bandages-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs | YouTube